MedTrace Logo

Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry

NCT06493994 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-01-03

No results posted yet for this study

Summary

Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).

Conditions

  • Aortic Valve Stenosis

Interventions

OTHER

transaxillary (TAX) transcatheter aortic valve replacement

Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).

Sponsors & Collaborators

  • University Hopsital Schleswig Holstein Campus Lübeck

    collaborator OTHER

  • University of Luebeck

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2027-01-30
Completion
2027-01-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06493994 on ClinicalTrials.gov